INSPIRE VETERINARY PARTNERS, INC. — fact timeline

INSPIRE VETERINARY PARTNERS, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“November 13, 2025, Inspire Veterinary Partners, Inc. (the “Company”) received a notice letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), for the prior 30 consecutive business days, the Company was not in compliance with the minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2). The Notice stated that the Company’s securities would be suspended from trading on The Nasdaq Capital Ma”

INSPIRE VETERINARY PARTNERS, INC. issued 2,500,000 shares of common stock to Target Capital 1 LLC.

“the Company and Target agreed to cancel $25,000 of the outstanding principal amount under that certain promissory note issued by the Company to Target on June 10, 2025, as amended (the “June Note”), in exchange for 2,500,000 shares of the Company’s Class A common stock”

INSPIRE VETERINARY PARTNERS, INC. entered into Cancellation and Exchange Agreement with Target Capital 1 LLC valued at $25,000 (effective 2026-01-14).

“On January 14, 2026, Inspire Veterinary Partners, Inc. (the “Company”), entered into a Cancellation and Exchange Agreement, (the “Agreement”) with Target Capital 1 LLC ( “Target”). Pursuant to the Agreement, the Company and Target agreed to cancel $25,000 of the outstanding principal amount under that certain promissory note issued by the Company to Target on June 10, 2025, as amended (the “June Note”), in exchange for 2,500,000 shares of the Company’s Class A common stock, par value $0.0001 per share.”

INSPIRE VETERINARY PARTNERS, INC. issued up to 2,500,000 shares of common stock of common stock to Manetto Hill Fund Series I LLC.

“Pursuant to the securities purchase agreement, in connection with the issuance of the Note, the Company agreed to issue up to 2,500,000 shares of common stock to Manetto (the “Commitment Shares”).”

INSPIRE VETERINARY PARTNERS, INC. issued convertible note to Manetto Hill Fund Series I LLC for $975,000 principal amount for a purchase price of $750,000.

“On January 6, 2026, effective as of December 31, 2025, the Company issued to a secured convertible promissory note in the principal amount of $975,000 for a purchase price of $750,000 (the “Note”).”

INSPIRE VETERINARY PARTNERS, INC. entered into securities purchase agreement with Manetto Hill Fund Series I LLC valued at up to an aggregate of $1,626,000 principal amount of convertible promissory notes (effective 2026-01-06).

“On January 6, 2026, effective as of December 31, 2025, Inspire Veterinary Partners, Inc. (the “Company”) entered into a securities purchase agreement with Manetto Hill Fund Series I LLC”

INSPIRE VETERINARY PARTNERS, INC. incurred convertible notes of up to an aggregate of $1,626,000 principal amount of convertible promissory notes with Manetto Hill Fund Series I LLC.

“On January 6, 2026, effective as of December 31, 2025, Inspire Veterinary Partners, Inc. (the "Company") entered into a securities purchase agreement with Manetto Hill Fund Series I LLC, a Delaware limited liability company ("Manetto") whereby the Company may issue up to an aggregate of $1,626,000 principal amount of convertible promissory notes in one or more closings, subject to the terms and conditions set forth therein.”

INSPIRE VETERINARY PARTNERS, INC. incurred convertible notes of $975,000 with Manetto Hill Fund Series I LLC at 10% per annum maturing December 31, 2026.

“On January 6, 2026, effective as of December 31, 2025, the Company issued to a secured convertible promissory note in the principal amount of $975,000 for a purchase price of $750,000 (the "Note").”

INSPIRE VETERINARY PARTNERS, INC. issued 3,000,000 shares of the Company's Class A common stock of common stock to Target Capital 1 LLC for cancellation of $150,000 of outstanding principal.

“On December 18, 2025, Inspire Veterinary Partners, Inc. (the “Company”), entered into a Cancellation and Exchange Agreement, (the “Agreement”) between the Company and Target Capital 1 LLC ( “Target”). Pursuant to the Agreement, the Company and Target agreed to cancel $150,000 of the outstanding principal amount under that certain promissory note issued by the Company to Target on June 10, 2025, as amended (the “June Note”), in exchange for 3,000,000 shares of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”).”

INSPIRE VETERINARY PARTNERS, INC. entered into Consulting Agreement with 622 Capital LLC valued at 9,450,000 shares of Class A common stock (effective 2025-12-12).

“On December 12, 2025, Inspire Veterinary Partners, Inc. (the “Company”) entered into a Consulting Agreement (the “Consulting Agreement”) with 622 Capital LLC, a single member limited liability company (the “Consultant”), pursuant to which the Consultant will provide the Company with business development services related to business financing opportunities.”

INSPIRE VETERINARY PARTNERS, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv)).

“November 13, 2025, Inspire Veterinary Partners, Inc. (the “Company”) received a notice letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share, for the prior 30 consecutive business days, the Company was not in compliance with the minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2). Further, the Notice stated that, pursuant to Listing Rule 5810(c)(3)(A)(iv), the Company was not eligible for any compliance period s”

INSPIRE VETERINARY PARTNERS, INC. issued convertible note to Keystone Capital Partners, LLC and Seven Knots, LLC for purchase price of each note was $125,000.

“On November 5, 2025, Inspire Veterinary Partners, Inc. (the “Company”) issued Senior Convertible Promissory Notes to Keystone Capital Partners, LLC and Seven Knots, LLC (the “Investors”), each in the principal amount of $178,571,43 with an original issue discount of 30% such that the purchase price of each note was $125,000”

INSPIRE VETERINARY PARTNERS, INC. incurred convertible notes of $178,571,43 with Keystone Capital Partners, LLC and Seven Knots, LLC at 10% per annum maturing August 5, 2026.

“On November 5, 2025, Inspire Veterinary Partners, Inc. (the “Company”) issued Senior Convertible Promissory Notes to Keystone Capital Partners, LLC and Seven Knots, LLC (the “Investors”), each in the principal amount of $178,571,43 with an original issue discount of 30% such that the purchase price of each note was $125,000 (each a “Note” and together, the “Notes”). Each Note bears interest at a rate of 10% per annum, payable monthly, and matures on August 5, 2026, unless earlier converted or repaid in accordance with its terms.”

INSPIRE VETERINARY PARTNERS, INC. engaged M&K CPAS, PLLC as its auditor.

“Effective October 16, 2025, the Company appointed M&K CPAS, PLLC (“M&K”) as the independent registered public accounting firm to audit the Company’s consolidated financial statements as of and for the fiscal year ended December 31, 2025.”

INSPIRE VETERINARY PARTNERS, INC. dismissed Kreit & Chiu CPA LLP as its auditor.

“On October 16, 2025, Inspire Veterinary Partners, Inc. (the “Company”) dismissed Kreit & Chiu CPA LLP (“K&C”) as the Company’s independent registered public accounting firm.”

INSPIRE VETERINARY PARTNERS, INC. issued related Warrants of warrant to certain institutional investors for gross proceeds of approximately $1.0 million.

“the Company and certain investors effected an Additional Closing (as defined in the Securities Purchase Agreement), with respect to 1,253 additional shares of Series B Preferred Stock and related Warrants for gross proceeds of approximately $1.0 million.”

INSPIRE VETERINARY PARTNERS, INC. issued 1,253 additional shares of Series B Preferred Stock of preferred stock to certain institutional investors for gross proceeds of approximately $1.0 million.

“the Company and certain investors effected an Additional Closing (as defined in the Securities Purchase Agreement), with respect to 1,253 additional shares of Series B Preferred Stock and related Warrants for gross proceeds of approximately $1.0 million.”

INSPIRE VETERINARY PARTNERS, INC.: Filed Certificate of Designations establishing Series B Preferred Stock (effective 2025-07-29).

“On July 28, 2025, the Company filed the Certificate of Designations for the purpose of designating and establishing the Company’s Series B Preferred Stock. The Certificate of Designations was filed pursuant to the Securities Purchase Agreement. The Certificate of Designations became effective on July 29, 2025.”

INSPIRE VETERINARY PARTNERS, INC. completed an acquisition involving Suarez Enterprises, LLC for $1,132,000, payable in cash (closed 2025-06-05).

“structures and fixtures, and all intangible property owned by the Suarez Enterprises in connection with the land or improvements, if any, for an aggregate purchase price of $1,132,000, payable in cash. The foregoing description of the Real Estate Asset Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full”

INSPIRE VETERINARY PARTNERS, INC. completed an acquisition involving Joseph A. Suarez, D.V.M., P.A. for $925,000 plus the assumed liabilities (closed 2025-06-05).

“and together with the Seller, the “Seller Parties”) completed the acquisition of the Debary Animal Clinic. The aggregate purchase consideration for the Debary Animal Clinic was $925,000 plus the assumed liabilities described below, consisting of $832,500 to be paid in cash at the closing of the acquisition plus 54,734 restricted shares of the Company’s Class A”

Kimball Carr was appointed as Chairman of the Board at INSPIRE VETERINARY PARTNERS, INC..

“appointed Kimball Carr, our current Chief Executive Officer, as Chairman of the Board”

INSPIRE VETERINARY PARTNERS, INC.: Increased authorized shares of Class A common stock to 100,000,000 (effective 2025-02-11).

“The Company filed a Certificate of Amendment with the Secretary of State of the State of Nevada, which became effective on February 11, 2025.”

INSPIRE VETERINARY PARTNERS, INC.: Filed a Certificate of Change to the Amended and Restated Certificate of Incorporation to effect a 1-for-25 reverse stock split, reducing authorized and issued shares proportionally (effective 2025-01-27).

“As previously disclosed in a Current Report on Form 8-K filed on January 10, 2025, Inspire Veterinary Partners, Inc., a Nevada corporation, (the “Company”) seeks to effect a one-for-twenty-five (1:25) reverse stock split (the “ Reverse Stock Split”) of its issued and outstanding shares of Class A common stock, $0.0001 par value per share (“Common Stock”). The Reverse Stock Split will become effective on January 27, 2025.”

INSPIRE VETERINARY PARTNERS, INC.: Filed Certificate of Change to effect a 1-for-25 reverse stock split of Common Stock and proportionally reduce authorized shares from 100,000,000 to 4,000,000 (effective 2025-01-03).

“On January 3, 2025, the Company filed a Certificate of Change to the Company’s Amended and Restated Certificate of Incorporation, as previously amended, with the Secretary of State of the State of Nevada to effect the Reverse Stock Split.”

INSPIRE VETERINARY PARTNERS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“December 16, 2024 , the Company received a letter from the Staff notifying the Company that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share, for the prior 30 consecutive business days, the Company was not in compliance with the minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided a grace period of 180 days, or until June 16, 2025, to regain compliance with the Minimum Bid Price Requirement. 1 SIGNATURES Pursuant to the req”

INSPIRE VETERINARY PARTNERS, INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5250(c)(1)).

“April 11, 2024, Inspire Veterinary Partners, Inc. (the “Company”) received a staff determination from The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, based on the Company’s stockholders’ equity of ($788,259) as reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 as filed with the Securities and Exchange Commission, the Company does not meet the alternatives of market value of listed securities or net income from continuing operations. As such, the Company no longer complies with Nasdaq’s Listing Rule (the “Rule”). Accordingly, this matter se”

INSPIRE VETERINARY PARTNERS, INC.: Lowered the floor price of the Series A preferred stock to $0.01 via a Certificate of Amendment to the Certificate of Designation (effective 2024-04-04).

“The Company filed a second Certificate of Amendment to the Certificate of Designation of its Series A preferred stock with the Nevada Secretary of State (the “Amendment”). Pursuant to the Amendment, the floor price of the Company’s Series A preferred stock was lowered to $0.01.”

INSPIRE VETERINARY PARTNERS, INC. entered into Purchase Agreement with certain investors valued at each for $250,000 (effective 2024-03-28).

“On March 28, Inspire Veterinary Partners, Inc. (the “Company”) entered into a securities purchase agreement (each a “Purchase Agreement”) with certain investors.”

INSPIRE VETERINARY PARTNERS, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5810(c)(3)(A)(iii)).

“March 8, 2024, Inspire Veterinary Partners, Inc. (the “Company”) received a staff determination from The Nasdaq Stock Market (“Nasdaq”) to delist the Company’s securities from the Nasdaq Capital Market (the “Staff Determination”). The Staff Determination was issued because, as of March 7, 2024, the Company’s securities had a closing bid price of $0.10 or less for at least ten consecutive trading days. Accordingly, the Company is subject to the provisions contemplated under Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”). The Company may appeal the Staff Determination, however, t”

INSPIRE VETERINARY PARTNERS, INC. entered into Securities Purchase Agreement with a purchaser (the “Purchaser”) (effective 2024-02-08).

“Also on February 8, 2024, Inspire entered into a securities purchase agreement (the “Securities Purchase Agreement”) with a purchaser (the “Purchaser”).”

INSPIRE VETERINARY PARTNERS, INC. entered into Placement Agency Agreement with Spartan Capital Securities, LLC valued at up to an aggregate of $4,000,000 (effective 2024-02-08).

“On February 8, 2024, Inspire Veterinary Partners, Inc. (“Inspire” or the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Spartan Capital Securities, LLC, pursuant to which the Company engaged Spartan to serve as the exclusive placement agent for the Company, on a “reasonable best-efforts” basis, in connection with the public offering (the “Offering”) of up to an aggregate of $4,000,000 of either (a) shares of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”) at a public offering price of $0.0850 per share, or (b) pre-funded warrants to subscribe for shares of Class A Common Stock (the “Pre-funded Warrants”) at a public offering price of $0.0849 per Pre-Funded Warrant.”

INSPIRE VETERINARY PARTNERS, INC. entered into Subscription Agreement with Target Capital 1, LLC valued at $200,000 (effective 2024-01-02).

“On January 2, 2024, Inspire Veterinary Partners, Inc. (“Inspire” or the “Company”) entered into a subscription agreement (the “Subscription Agreement”) with Target Capital 1, LLC (“Target”), pursuant to which Target purchased 20,000 shares of Series A preferred stock for gross proceeds of $200,000.”

INSPIRE VETERINARY PARTNERS, INC. amended Common Stock Purchase Agreement Amendment with Tumim Stone Capital LLC valued at Amendments to commitment share issuance threshold at 4.99% beneficial ownership, warrant with exerci (effective 2023-12-28).

“On December 28, 2023, Inspire Veterinary Partners, Inc. ("Inspire" or the "Company") entered into an agreement (the "Agreement") with Tumim Stone Capital LLC (the "Investor"), pursuant to which the Investor and the Company agreed to certain amendments to the previously disclosed common stock purchase agreement (the "Purchase Agreement") and the registration rights agreement (the "Registration Rights Agreement"), each dated as of November 30, 2023, by and between the Company and the Investor.”

INSPIRE VETERINARY PARTNERS, INC. entered into Purchase Agreement with Tumim Stone Capital LLC valued at up to $30 million (effective 2023-11-30).

“On November 30, 2023, Inspire Veterinary Partners, Inc. (“Inspire” or the “Company”) entered into a common stock purchase agreement (the “Purchase Agreement”) with Tumim Stone Capital LLC (the “Investor”), pursuant to which the Investor has committed to purchase, subject to certain conditions and limitations, up to $30 million (the “Total Commitment”) of shares of Inspire’s Class A common stock”

INSPIRE VETERINARY PARTNERS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“November 27, 2023, Inspire Veterinary Partners, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company’s common stock is subject to potential delisting from the Nasdaq because for a period of 30 consecutive business days, the bid price of the Company’s common stock has closed below the minimum $1.00 per share requirement for continued inclusion under Nasdaq Marketplace Rule 5550(a)(2) (the “Bid Price Rule”). The Nasdaq deficiency letter has no immediate effect on the listing of the Company’s”

INSPIRE VETERINARY PARTNERS, INC. reported third quarter of 2023 results: revenue $4.1 million, net income $7.9 million.

“Total revenue was $4.1 million for the third quarter of 2023, an increase of 42% compared to total revenue of $2.9 million in the prior year period”

INSPIRE VETERINARY PARTNERS, INC.: On November 7, 2023, Inspire Veterinary Partners, Inc. filed an amendment to its certificate of designation for Series A preferred stock to increase the number of designated Series A preferred shares to 2,000,000 and modify the conversion price to no less than $0.25 per share (effective 2023-11-07).

“On November 7, 2023, Inspire Veterinary Partners, Inc. (the “Company”) amended its articles of incorporation by filing with the Secretary of State of the State of Nevada an amendment (the “Series A COD Amendment”) to the certificate of designation for the Company’s Series A preferred stock (the “Series A Preferred Stock”).”

INSPIRE VETERINARY PARTNERS, INC.: Increased Series A Preferred Stock authorized shares to 2,000,000 and modified conversion price to no less than $0.50 per share (effective 2023-11-07).

“On November 7, 2023, Inspire Veterinary Partners, Inc. (the “Company”) amended its articles of incorporation by the filing with the Secretary of State of the State of Nevada an amendment (the “Series A COD Amendment”) to the certificate of designation for the Company’s Series A preferred stock (the “Series A Preferred Stock”).”

INSPIRE VETERINARY PARTNERS, INC. completed an acquisition involving Michelle Bartus, VMD and Peter Nelson, VMD (the Owners) for aggregate purchase price of $590,000 (closed 2023-11-08).

“improvements, structures and fixtures, and all intangible property owned by the Owners in connection with the land or improvements, if any, for an aggregate purchase price of $590,000, payable in cash. The foregoing description of the Real Estate Asset Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full”

INSPIRE VETERINARY PARTNERS, INC. completed an acquisition involving Valley Veterinary Service, Inc. for aggregate purchase consideration of $1,400,000 plus assumed liabilities, consisting of $1,000,000 in cash and 408,163 restricted shares of Class A common stock (closed 2023-11-08).

“completed the acquisition of Valley Veterinary Services animal hospital. The aggregate purchase consideration for the Valley Veterinary Services animal hospital practice was $1,400,000 plus the assumed liabilities described below, consisting of $1,000,000 to be paid in cash at the closing of the acquisition plus 408,163 restricted shares of the Company’s Class A”

INSPIRE VETERINARY PARTNERS, INC. entered into Real Estate Asset Purchase Agreement with Michelle Bartus, VMD and Peter Nelson, VMD valued at $590,000 aggregate purchase price payable in cash (effective 2023-10-27).

“Also on October 27, 2023, IVP PA Properties, LLC (“RE AcquisitionSub”), a Delaware limited liability company and wholly-owned subsidiary of the Company, and the Owners entered into a real estate asset purchase agreement (the “Real Estate Asset Purchase Agreement”) with respect to certain real estate assets related to the Valley Veterinary Service animal hospital located at 408 Grace Lane, Rostraver Township, Pennsylvania 15012 (Parcel Nos. 56-12-00-0-148 and 56-12-00-0-144).”

INSPIRE VETERINARY PARTNERS, INC. entered into Asset Purchase Agreement with Valley Veterinary Service, Inc., Michelle Bartus, VMD and Peter Nelson, VMD valued at $1,400,000 aggregate purchase consideration comprising $1,000,000 cash plus restricted shares of Cla (effective 2023-10-27).

“On October 27, 2023, Inspire Veterinary Partners, Inc. (the “Company”) and IVP PA Holding Company, LLC (“AcquisitionSub”), a Delaware limited liability company and wholly-owned subsidiary of the Company, entered into an asset purchase agreement (the “Asset Purchase Agreement”) with Valley Veterinary Service, Inc., a Pennsylvania corporation (the “Seller”), Michelle Bartus, VMD and Peter Nelson, VMD (the “Owners” and together with the Seller, the “Seller Parties”), related to the acquisition of Valley Veterinary Service animal hospital.”

INSPIRE VETERINARY PARTNERS, INC. entered into Underwriting Agreement with Spartan Capital Securities, LLC valued at approximately $5,363,000 (effective 2023-08-29).

“On August 29, 2023, Inspire Veterinary Partners, Inc., a Nevada corporation (the “Company”), entered into an underwriting agreement (the “Underwriting Agreement”) with Spartan Capital Securities, LLC”